FDG-PET/CT在食管鳞癌颈部淋巴结分期中的作用
前瞻性纳入110例可切除食管癌患者,术前行FDG-PET/CT后行三野淋巴结清扫,以术后病理为金标准评估颈部淋巴结转移诊断价值。FDG-PET/CT诊断颈部淋巴结转移的敏感度45.0%、特异度95.6%、准确率86.4%,特异度高但敏感度低,价值有限。
要点
- FDG-PET/CT诊断食管鳞癌颈部淋巴结转移敏感度仅45.0%,易漏诊。
- FDG-PET/CT诊断颈部淋巴结转移特异度达95.6%,阳性预测值69.2%。
- FDG-PET/CT与颈部超声诊断颈部淋巴结转移无显著差异。
核心结论
- FDG-PET/CT对食管鳞癌颈部淋巴结转移诊断特异度高但敏感度低,应用价值有限。
研究设计与样本
- 前瞻性研究,2018年6月至11月纳入110例可切除食管癌患者,术前行FDG-PET/CT后行食管切除加三野淋巴结清扫。
主要发现
- FDG-PET/CT阳性淋巴结患者61例(55.5%),其中颈部淋巴结阳性13例(11.8%)。
- 术后病理淋巴结转移59例(53.6%),其中颈部淋巴结转移20例(18.2%)。
- 诊断总体淋巴结转移的敏感度65.6%、特异度61.2%、阳性预测值67.8%、阴性预测值58.8%、准确率63.6%。
- 诊断颈部淋巴结转移的敏感度45.0%、特异度95.6%、阳性预测值69.2%、阴性预测值88.7%、准确率86.4%。
- 110例中90例同时行FDG-PET/CT和颈部超声,两者诊断颈部淋巴结转移的各诊断效能指标无显著差异。
关键数值与推荐
- 以术后组织学结果为参考标准,FDG-PET/CT诊断颈部淋巴结转移敏感度45.0%、特异度95.6%。
临床怎么用
- FDG-PET/CT高特异度可用于确认颈部淋巴结转移,但低敏感度提示阴性结果不能排除转移。
- FDG-PET/CT与颈部超声诊断效能无显著差异,临床可结合两者综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Accurate nodal staging is crucial for esophageal cancer. A prospective study was performed to assess the value of [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) for diagnosing cervical lymph node metastasis (LNM) of esophageal squamous cell carcinoma. METHODS: From June 2018 to November 2018, 110 patients with resectable esophageal cancer were prospectively enrolled. Esophagectomy with 3-field lymphadenectomy was performed after FDG-PET/CT scanning. The primary end point was cervical LNM determined via postoperative histologic examination. The sensitivity (SE), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and accuracy (AC) of FDG-PET/CT for the assessment of LNM were determined using histologic results as reference standards. RESULTS: Positive lymph nodes as determined via FDG-PET/CT were detected in 61 patients (55.5%), of whom 13 (11.8%) had positive cervical lymph nodes. After surgery, 59 patients (53.6%) exhibited pathologic LNM, of whom 20 (18.2%) had cervical LNM. SE, SP, PPV, NPV, and AC were 65.6%, 61.2%, 67.8%, 58.8%, and 63.6%, respectively, with regards to diagnosing overall LNM, and were 45.0%, 95.6%, 69.2%, 88.7%, and 86.4%, respectively, for diagnosing cervical LNM. Of the 110 patients, 90 underwent both FDG-PET/CT scanning and ultrasonography in the neck, and there were no significant differences in SE, SP, PPV, NPV, or AC with respect to cervical LNM diagnosis between FDG-PET/CT and ultrasonography. CONCLUSIONS: For cervical LNM of esophageal squamous cell carcinoma, FDG-PET/CT scanning exhibited high specificity but low sensitivity, suggesting that it is of limited value for this purpose.
引用
- Li B, Li N, Liu S, et al. Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma? J Thorac Cardiovasc Surg. 2019. PMID: 31932053. doi:10.1016/j.jtcvs.2019.11.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。